Literature DB >> 20036939

Cancer stem cell and niche.

Daotai Nie1.   

Abstract

Recent research on cancer has generated a new model for cancer growth-cancer stem cell model. This model can explain the inefficiency of conventional therapy. Tumor tissue, like normal tissue, is continuously repopulated from pools of self-renewing stem cells growing in a "niche", which is made up of a specialized vascular bed of endothelial cells, associated cells of mesenchymal origin and extracellular matrix components. In this review, we will introduce the models of cancer development, the roles of stem cells in tumor progression, the components of niche which affects the cell fate of cancer stem cells (CSCs), their different regulatory factors, as well as the clinical implication of CSCs in cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20036939     DOI: 10.2741/s56

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  10 in total

1.  Cancer: Chemotherapy counteracted.

Authors:  Urban Emmenegger; Robert S Kerbel
Journal:  Nature       Date:  2010-12-02       Impact factor: 49.962

Review 2.  Stem cell niches and endogenous electric fields in tissue repair.

Authors:  Li Li; Jianxin Jiang
Journal:  Front Med       Date:  2011-03-17       Impact factor: 4.592

3.  CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance.

Authors:  Thorsten Jung; Wolfgang Gross; Margot Zöller
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

Review 4.  Mesenchymal stem cell secretome and regenerative therapy after cancer.

Authors:  Ludovic Zimmerlin; Tea Soon Park; Elias T Zambidis; Vera S Donnenberg; Albert D Donnenberg
Journal:  Biochimie       Date:  2013-06-05       Impact factor: 4.079

5.  The invasion and metastasis promotion role of CD97 small isoform in gastric carcinoma.

Authors:  Daren Liu; Bogusz Trojanowicz; Longyun Ye; Chao Li; Luqing Zhang; Xiaowen Li; Guogang Li; Yixiong Zheng; Li Chen
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

6.  Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors.

Authors:  Ayesha B Alvero; Michele K Montagna; Natalia J Sumi; Won Duk Joo; Emma Graham; Gil Mor
Journal:  Oncotarget       Date:  2014-09-30

7.  BRCA1 regulates the cancer stem cell fate of breast cancer cells in the context of hypoxia and histone deacetylase inhibitors.

Authors:  Hoon Kim; Qun Lin; Zhong Yun
Journal:  Sci Rep       Date:  2019-07-04       Impact factor: 4.379

Review 8.  Thyroid tumor-initiating cells: increasing evidence and opportunities for anticancer therapy (review).

Authors:  Yong-Ju Gao; Bo Li; Xin-Yu Wu; Jing Cui; Jian-Kui Han
Journal:  Oncol Rep       Date:  2014-01-14       Impact factor: 3.906

Review 9.  Cancer stem cells (CSCs), cervical CSCs and targeted therapies.

Authors:  Ruixia Huang; Einar K Rofstad
Journal:  Oncotarget       Date:  2017-05-23

10.  CD44+ cells determine fenofibrate-induced microevolution of drug-resistance in prostate cancer cell populations.

Authors:  Tomasz Wróbel; Marcin Luty; Jessica Catapano; Elżbieta Karnas; Małgorzata Szczygieł; Katarzyna Piwowarczyk; Damian Ryszawy; Grażyna Drabik; Ewa Zuba-Surma; Maciej Siedlar; Zbigniew Madeja; Martyna Elas; Jarosław Czyż
Journal:  Stem Cells       Date:  2020-09-27       Impact factor: 6.277

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.